Bing Xu

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Venues

Oncogenesis

Cell death & disease

Hepatology communications

Research (Washington, D.C.)

This page only lists publications with an associated author ORCID identifier.

Publications

Tianming Zhao, Hanlong Zhu, Tianhui Zou, Si Zhao, Lin Zhou, Muhan Ni, Feng Liu, Hao Zhu, Xiaotan Dou, Jian Di, Bing Xu, Lei Wang, Xiaoping Zou
DDX3X interacts with SIRT7 to promote PD-L1 expression to facilitate PDAC progression. Oncogenesis 13 (1) (2024)
Tianming Zhao, Hanlong Zhu, Tianhui Zou, Si Zhao, Lin Zhou, Muhan Ni, Feng Liu, Hao Zhu, Xiaotan Dou, Jian Di, Bing Xu, Lei Wang, Xiaoping Zou
DDX3X interacts with SIRT7 to promote PD-L1 expression to facilitate PDAC progression. Oncogenesis 13 (1) (2024)
Tianming Zhao, Hanlong Zhu, Tianhui Zou, Si Zhao, Lin Zhou, Muhan Ni, Feng Liu, Hao Zhu, Xiaotan Dou, Jian Di, Bing Xu, Lei Wang, Xiaoping Zou
DDX3X interacts with SIRT7 to promote PD-L1 expression to facilitate PDAC progression. Oncogenesis 13 (1) (2024)
Suzhen Yang, Lin Zhou, Tianming Zhao, Hanlong Zhu, Tingting Luo, Kang Jiang, Xiaoxiao Shi, Chunyan Chen, Han Zhang, Si Zhao, Xiaoping Zou, Yuzheng Zhuge, Fangyu Wang, Lei Wang, Mingzuo Jiang, Bing Xu
Protective and Adverse Roles of DDX3X in Different Cell Types in Nonalcoholic Steatohepatitis Progression. Research (Washington, D.C.) 6 (2023)
Tingting Luo, Suzhen Yang, Tianming Zhao, Hanlong Zhu, Chunyan Chen, Xiaoxiao Shi, Di Chen, Kai Wang, Kang Jiang, Dan Xu, Ming Cheng, Juan Li, Wenting Li, Weijun Xu, Lin Zhou, Mingzuo Jiang, Bing Xu
Hepatocyte DDX3X protects against drug-induced acute liver injury via controlling stress granule formation and oxidative stress. Cell death & disease 14 (7) (2023)
Jiayi Cao, Suzhen Yang, Tingting Luo, Rui Yang, Hanlong Zhu, Tianming Zhao, Kang Jiang, Bing Xu, Yingchun Wang, Fulin Chen
TATA-box-binding protein promotes hepatocellular carcinoma metastasis through epithelial-mesenchymal transition. Hepatology communications 7 (7) (2023)
Yuying Han, Xiaoliang Gao, Nan Wu, Yirong Jin, He Zhou, Weijie Wang, Hao Liu, Yi Chu, Jiayi Cao, Mingzuo Jiang, Suzhen Yang, Yanting Shi, Xin Xie, Fulin Chen, Ying Han, Wen Qin, Bing Xu, Jie Liang
Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize Nrf2. Cell death & disease 13 (8) (2022)
Xiaochun Yin, Jin Peng, Lihong Gu, Yan Liu, Xihan Li, Jinhui Wu, Bing Xu, Yuzheng Zhuge, Feng Zhang
Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis. Cell death & disease 13 (11) (2022)

Bing Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bing Xu